Clinical Course and Prognosis of Tubulopathies Characterized by Metabolic Alkalosis in Children

Objective: Bartter syndrome and Gitelman syndrome are rare inherited tubulopathies characterized by hypokalemic, hypochloremic metabolic alkalosis. This study aimed to clarify the frequency of the phenotypic and genotypic subgroups, clinical features, long-term management, and prognosis of children diagnosed with Bartter syndrome and Gitelman syndrome in this study. Materials and Methods: Twenty-seven patients with Bartter syndrome and 6 patients with Gitelman syndrome, who were followed up between 2004 and 2020 in a single center, were included in the study. Results: The median age of diagnosis was 4 months in patients with Bartter syndrome and 174 months in patients with Gitelman syndrome. At the last follow-up, a total of 12 Bartter syndrome patients had chronic kidney disease with a mean 7.79 ± 4.73 years of age; 5 (18.5%) of these patients had chronic kidney disease stage 2, 5 (18.5%) had chronic kidney disease stage 3, and 2 (7.4%) had chronic kidney disease stage 5. Of the 5 patients with Bartter syndrome with chronic kidney disease stage 2, 2 had CLCNKB and 1 had SLC12A1 gene mutation. Also, CLCNKB mutation was detected in 2 of 5 patients with Bartter syndrome with chronic kidney disease stage 3. Finally, 2 patients with Bartter syndrome with chronic kidney disease stage 5 had BSND mutation in one and CLCNKB mutation in the other. Estimated glomerular filtration rates of all patients with Gitelman syndrome were normal at the last follow-up. There was no statistically significant association of development of chronic kidney disease with genetic mutation, nephrocalcinosis, prematurity, and hypokalemia. Conclusion: Patients with Bartter syndrome and Gitelman syndrome may have a different clinical course due to the underlying genetic mutation. Bartter syndrome and Gitelman syndrome require lifelong treatment, and regular follow-up is important to prevent advanced-stage chronic kidney disease.

[1]  G. Capasso,et al.  Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders. , 2021, Kidney international.

[2]  R. Kleta,et al.  Inherited Tubulopathies of the Kidney: Insights from Genetics. , 2020, Clinical journal of the American Society of Nephrology : CJASN.

[3]  E. Sevinç,et al.  SLC26A3 mutation in Turkish neonate and her sibling with congenital chloride diarrhea , 2018, Turk pediatri arsivi.

[4]  Zhiying Liu,et al.  Thirteen novel CLCNKB variants and genotype/phenotype association study in 42 Chinese patients with Bartter syndrome type 3 , 2019, Endocrine.

[5]  R. Kleta,et al.  Bartter and Gitelman syndromes: Questions of class , 2019, Pediatric Nephrology.

[6]  R. Kleta,et al.  Salt-Losing Tubulopathies in Children: What's New, What's Controversial? , 2017, Journal of the American Society of Nephrology : JASN.

[7]  R. Kleta,et al.  Clinical and diagnostic features of Bartter and Gitelman syndromes , 2017, Clinical kidney journal.

[8]  D. Bolignano,et al.  Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. , 2017, Kidney international.

[9]  E. Avner,et al.  Renal tubular disorders of electrolyte regulation in children , 2015 .

[10]  Brenda R. Hemmelgarn,et al.  Notice , 2012, Kidney International Supplements.

[11]  M. Buyukcelik,et al.  Bartter syndrome and growth hormone deficiency: three cases , 2012, Pediatric Nephrology.

[12]  H. Cheong,et al.  Genetic basis of Bartter syndrome in Korea. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  R. Topaloğlu,et al.  Hereditary renal tubular disorders in Turkey: demographic, clinical, and laboratory features , 2011, Clinical and Experimental Nephrology.

[14]  C. Guyot,et al.  Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  Susan L Furth,et al.  New equations to estimate GFR in children with CKD. , 2009, Journal of the American Society of Nephrology : JASN.

[16]  H. Seyberth An improved terminology and classification of Bartter-like syndromes , 2008, Nature Clinical Practice Nephrology.

[17]  Gülbin Gökçay,et al.  Türk çocuklarında vücut ağırlığı, boy uzunluğu, baş çevresi ve vücut kitle indeksi referans değerleri , 2008 .

[18]  B. Tönshoff,et al.  Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. , 2002, The American journal of medicine.

[19]  J. Gill,et al.  Hyperplasia of the Juxtaglomerular Complex with Hyperaldosteronism and Hypokalemic Alkalosis. , 1963 .